Streetbeat News

Revenues

EXC

Exelon (NASDAQ:EXC) reported Q3 2024 earnings per share of $0.71, surpassing the analyst estimate of $0.67. Sales reached $6.154 billion, exceeding the expected $5.854 billion. Both earnings and sales showed year-over-year growth.

Portfolio Pulse from Benzinga Newsdesk

October 30, 2024 | 10:53 am

OSW

Onespaworld Holdings has increased its fiscal 2024 revenue guidance to $888M-$893M from the previous $870M-$890M, surpassing the estimate of $887.81M. Additionally, the company has raised its adjusted EBITDA guidance to $110M-$112M from $102M-$108M.

Portfolio Pulse from Benzinga Newsdesk

October 30, 2024 | 10:53 am

GLT

Glatfelter reported Q3 sales of $332.10 million, a slight increase from $329.92 million year-over-year.

Portfolio Pulse from Benzinga Newsdesk

October 30, 2024 | 10:53 am

HR

Healthcare Realty Trust reported Q3 normalized FFO per share of $0.39, consistent with the previous year. However, sales decreased to $315.42 million from $342.26 million last year.

Portfolio Pulse from Benzinga Newsdesk

October 30, 2024 | 10:49 am

MTRN

Materion reported Q3 2024 earnings per share of $1.41, meeting analyst expectations. The company's sales were $436.715 million, surpassing the $416.400 million estimate and marking an 8.35% increase from the previous year.

Portfolio Pulse from Benzinga Newsdesk

October 30, 2024 | 10:49 am

RDDT

Reddit shares surged following the release of their Q3 financial results, which exceeded expectations. The company also provided Q4 revenue guidance that surpassed estimates.

Portfolio Pulse from Benzinga Newsdesk

October 30, 2024 | 10:48 am

LLY

Eli Lilly has updated its 2024 financial guidance, lowering its revenue expectations to $45.4B-$46.0B from a previous range of $45.4B-$46.6B. The company is investing in tirzepatide supply and has adjusted its EPS guidance due to various charges, including the acquisition of Morphic Holding.

Portfolio Pulse from Benzinga Newsdesk

October 30, 2024 | 10:48 am

AVNS

Avanos Medical reported Q3 2024 earnings per share of $0.36, slightly beating the estimate of $0.35. However, sales were $170.4 million, missing the expected $175.333 million and showing a slight decrease from last year's $171.3 million.

Portfolio Pulse from Benzinga Newsdesk

October 30, 2024 | 10:47 am

EEX

Emerald Holding anticipates its fiscal year 2024 revenue to be at least $400 million, which is below the estimated $422.7 million.

Portfolio Pulse from Benzinga Newsdesk

October 30, 2024 | 10:46 am

NI

NiSource reaffirms its FY24 adjusted EPS guidance of $1.70-$1.74 and projects FY25 adjusted EPS in the range of $1.84-$1.88. The company plans a 6-8% annual EPS growth through 2029, driven by $19.3 billion in capital expenditures and 8-10% rate base growth.

Portfolio Pulse from Benzinga Newsdesk

October 30, 2024 | 10:38 am